Core Viewpoint - Vir Biotechnology is focused on harnessing the human immune system to combat both infectious diseases and cancer, aiming to deliver transformational therapies for serious unmet medical needs [2][3]. Group 1: Company Overview - Vir Biotechnology is making swift progress across its pipeline in infectious disease and oncology [2]. - The company has a deep understanding of immunology since its inception, enabling the development of innovative solutions for serious diseases [3]. Group 2: Research and Development Focus - The company aims to utilize its powerful R&D engine to address devastating diseases in both infectious disease and oncology [3].